PS
Pawankumar Sandipan Kakde
About Pawankumar Sandipan Kakde
Data last updated:
Pawankumar Sandipan Kakde is a Director at Emerging Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals. Emerging Pharmaceuticals Private Limited reported revenue of ₹79 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Emerging Pharmaceuticals Private Limited U74120MH2014PTC256510 | Director | 24 Jul 2014 | 2014 | ₹79 Lakh (FY 2024) | Active |
Board colleagues of Pawankumar Sandipan Kakde
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sonali Balu Kale | 10109523 | Emerging Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pawankumar Sandipan Kakde
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pawankumar Sandipan Kakde
Pawankumar Sandipan Kakde currently holds 1 directorship: Emerging Pharmaceuticals Private Limited (Director, since 24 Jul 2014, revenue ₹79 Lakh (FY 2024)).
Pawankumar Sandipan Kakde was first appointed on 24 Jul 2014 as Director at Emerging Pharmaceuticals Private Limited.
The current boards of Pawankumar Sandipan Kakde's companies include Sonali Balu Kale (Emerging Pharmaceuticals Private Limited).